Merck & Co Inc (MRK)
130.04
+3.04
(+2.39%)
USD |
NYSE |
Apr 25, 12:30
Merck Accounts Receivable (Quarterly): 10.35B for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 10.35B |
September 30, 2023 | 10.39B |
June 30, 2023 | 11.03B |
March 31, 2023 | 10.42B |
December 31, 2022 | 9.45B |
September 30, 2022 | 9.482B |
June 30, 2022 | 9.643B |
March 31, 2022 | 9.828B |
December 31, 2021 | 9.23B |
September 30, 2021 | 8.571B |
June 30, 2021 | 7.843B |
March 31, 2021 | 8.235B |
December 31, 2020 | 6.803B |
September 30, 2020 | 8.422B |
June 30, 2020 | 7.577B |
March 31, 2020 | 8.182B |
December 31, 2019 | 6.778B |
September 30, 2019 | 8.442B |
June 30, 2019 | 7.964B |
March 31, 2019 | 7.608B |
December 31, 2018 | 7.071B |
September 30, 2018 | 7.374B |
June 30, 2018 | 7.287B |
March 31, 2018 | 7.245B |
December 31, 2017 | 6.873B |
Date | Value |
---|---|
September 30, 2017 | 7.671B |
June 30, 2017 | 7.439B |
March 31, 2017 | 7.066B |
December 31, 2016 | 7.018B |
September 30, 2016 | 7.364B |
June 30, 2016 | 6.916B |
March 31, 2016 | 6.85B |
December 31, 2015 | 6.484B |
September 30, 2015 | 6.414B |
June 30, 2015 | 6.51B |
March 31, 2015 | 6.67B |
December 31, 2014 | 6.626B |
September 30, 2014 | 6.515B |
June 30, 2014 | 7.022B |
March 31, 2014 | 7.188B |
December 31, 2013 | 7.184B |
September 30, 2013 | 7.578B |
June 30, 2013 | 7.779B |
March 31, 2013 | 7.965B |
December 31, 2012 | 7.672B |
September 30, 2012 | 7.952B |
June 30, 2012 | 8.152B |
March 31, 2012 | 8.726B |
December 31, 2011 | 8.261B |
September 30, 2011 | 8.136B |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
6.778B
Minimum
Dec 2019
11.03B
Maximum
Jun 2023
8.876B
Average
8.571B
Median
Sep 2021
Accounts Receivable (Quarterly) Benchmarks
Amgen Inc | 7.268B |
Johnson & Johnson | 14.87B |
Eli Lilly and Co | 9.090B |
Pfizer Inc | 11.18B |
Moderna Inc | 892.00M |